Within the scope of general corporate mission, DEVA establishes long-term collaborations with international partners to carry its pharmaceutical products and operations on a global scale.

Strengths of DEVA as a reliable source:

Extensive Manufacturing Capabilities

Almost all pharmaceutical forms such as - tablets, capsules, suspensions, syrups, gels, pomades, creams, powders for injectables in vials & ampoules, eye drops, suppositories, nebules, inhalers as MDIs and DPIs - can be manufactured at DEVA Manufacturing facilities.

Broad range of products

DEVA has medicines combating diseases in the cardiovascular system, gastrointestinal system, central nervous system, respiratory system, dermatology, ophthalmology and oncology.

In-house development at its own certified R&D Center

R&D activities are conducted at dedicated laboratories, which were certified as an R&D center in May 2010, with its 150 scientists.

Dedicated commercial and regulatory teams

DEVA  has a dedicated and experienced team of specialists in its International Regulatory Affairs department who contribute to DEVA’s continuous success by preparing dossiers according to country specific regulations.

Commercial International Markets team reach almost all markets worldwide for market access though distribution or out-license models and provide focused account management to each partner.


CPhI Worldwide, being the world’s largest and most extensive pharmaceutical fair, has taken place in Madrid between 13- 15 October this year. DEVA held meetings with more than 100 business partners from nearly 25 countries at the fair gathering the global suppliers and drug manufacturers together in order to allow them to operate for competitive costs in their own markets in addition to providing raw material, machine, packaging solutions and contract services, and became one of the most interesting companies thanks to its wide product range and manufacturing capacity.


 DEVA Presentation



ADDRESS: Halkalı Merkez Mah. Basın Ekspres Caddesi No:1 KÜÇÜKÇEKMECE / İSTANBUL

TELEPHONE: +90 (212) 692 92 92 (PBX)

FAX: +90 (212) 697 00 24




DEVA Holding exports its finished products and APIs to more than 25 countries.

Currently DEVA Holding holds more than 300 Marketing Authorizations in the international markets including EU countries.

International operations of DEVA Holding  in the pharmaceutical industry are based on the following main business models:

-          Distribution

-          Out-license & Supply

-          Direct Sales Of DEVA Branded Products

-          Contract manufacturing

-          Co-development